Skip to content
OpenCapital
Get started

MacroGenics MGNX Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$72.8MBeat by $45.0MDiluted EPS$0.27Beat by $0.75
Revenue estimate$27.8M
EPS estimate-$0.48

Next report

Aug 13, 2026 (in a month)
Revenue estimate$68.0M
EPS estimate$0.03

Versus estimates

Revenue

Q1 2026$20.8MBeat by $5.5MQ4 2025$41.2MBeat by $6.6M
Q3 2025$72.8MBeat by $45.0M
Q2 2025$22.2MMiss by $2.2MQ1 2025$13.2MBeat by $1.4MQ4 2024$17.7MMiss by $16.4M

Diluted EPS

Q1 2026-$0.58Miss by $0.01Q4 2025-$0.22Beat by $0.20
Q3 2025$0.27Beat by $0.75
Q2 2025-$0.57Beat by $0.02Q1 2025-$0.65Miss by $0.04Q4 2024-$0.25Miss by $0.02

Ask the moment MacroGenics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MacroGenics report Q3 2025 earnings?
MacroGenics (MGNX) reported Q3 2025 earnings on November 12, 2025 before market open.
What were MacroGenics's Q3 2025 revenue and EPS?
MacroGenics reported revenue of $72.8M and diluted EPS of $0.27 for Q3 2025.
Did MacroGenics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $27.8M by $45.0M. EPS beat the consensus estimate of $-0.48 by $0.75.
How did MacroGenics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 34.2% from $110.7M a year earlier and diluted EPS declined 70.0% from $0.90.
Where can I find MacroGenics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001125345-25-000109) and the 10-Q periodic report (0001125345-25-000108) directly on SEC EDGAR. The filing index links above go to sec.gov.